EDGAR Filing Documents for 0001104659-17-023372

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-17-023372

Filing Date

2017-04-13

Accepted

2017-04-13 16:15:42

Documents

Period of Report

2017-04-13

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	a17-11228_16k.htm	6-K	17065
2	EX-99.1	a17-11228_1ex99d1.htm	EX-99.1	65723
3	EX-99.2	a17-11228_1ex99d2.htm	EX-99.2	1991770
4	EX-99.3	a17-11228_1ex99d3.htm	EX-99.3	6457
5	GRAPHIC	g112281mqi001.gif	GRAPHIC	116586
6	GRAPHIC	g112281mqi002.gif	GRAPHIC	100058
7	GRAPHIC	g112281mmi001.gif	GRAPHIC	7655
	Complete submission text file	0001104659-17-023372.txt		2391264

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 6-K | Act: 34 | File No.: 001-37569 | Film No.: 17760813
SIC: 2834 Pharmaceutical Preparations